Nanexa AB
556833-0285ActiveNanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Overview
- 10–19
- Employees
- 5–10M SEK
- Revenue
- 2010
- Founded
Key Decision Makers
David Westberg
CEO
Göran Ando
Chairman of the Board
Jonas Fransson
Head of Pharmaceutical Development
Mårten Rooth
CTO
+3 more contacts in Funnelfeedr
Description
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556833028501
Decision Makers
7 contacts in FunnelfeedrDavid Westberg
CEO
Göran Ando
Chairman of the Board
Jonas Fransson
Head of Pharmaceutical Development
Mårten Rooth
CTO
Cecilia Danckwardt-Lillieström
Chief Financial Officer
Björn Svanström
current CFO (leaving)
Bengt Gustavsson
Medical Director
Similar Companies
20 similar companies in Funnelfeedr
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Iconovo AB
10–19 employeesLeading partner developing patented dry powder inhaler drug delivery systems.
Double Bond Pharmaceutical AB
5–9 employeesDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
AcroPharma AB (publ)
0 employeesDeveloping innovative preventive therapeutics for major human diseases.
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
Browse More
Nanexa AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo